Back to article
Chamath Palihapitiya

Retatrutide hits 28% weight loss in Phase 3 (opens in new tab)

Covers 5 stories See all stories this covers including SpaceX S-1Discussed on Substack

Covers 5 related stories

sec.gov·

SpaceX S-1

Discussed on Hacker News
Feeds
TechCrunch·

Anthropic will pay xAI $1.25 billion per month for compute

Feeds
investor.lilly.com·

Lilly's triple agonist, retatrutide, delivered powerful weight loss in pivotal Phase 3 obesity trial

Discussed on r/longevity
Feeds
stratechery.com·

The Inference Shift

Discussed on Hacker News
Feeds
news.gallup.com·

Obesity Rate Declining in U.S. Use of GLP-1 injectables for weight loss has more than doubled since early 2024

Discussed on Hacker News and Hacker News
Feeds

Keyboard Shortcuts

Navigation

Next / previous post
j/k
Open post
oorEnter
Preview post
v

Post Actions

Love post
a
Like post
l
Dislike post
d
Undo reaction
u
Save / unsave
s

Recommendations

Add interest / feed
Enter
Not interested
x

Go to

Home
gh
Interests
gi
Feeds
gf
Likes
gl
History
gy
Changelog
gc
Settings
gs
Discover
gb
Search
/

General

Show this help
?
Submit feedback
!
Close modal / unfocus
Esc

Press ? anytime to show this help